FDA approval of OxyContin for children raises concerns

The U.S. Food and Drug Administration’s decision this month to approve the narcotic painkiller OxyContin for use in children as young as 11 has raised a host of questions for parents, doctors and those who help treat addiction in juveniles. Among them: Will the stamp of approval from the FDA lead to better research and […]